Status:
COMPLETED
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
UNITAID
Aurum Institute
Conditions:
Tuberculosis Infection
Tuberculosis Prevention
Eligibility:
All Genders
18+ years
Brief Summary
This qualitative study is designed to elicit the perspectives of relevant stakeholders to adapt a community-based TB/HIV intervention aimed on providing home-based TB prevention treatment (TPT) initia...
Detailed Description
Tuberculosis (TB) remains a top 10 cause of child mortality in sub-Saharan Africa. Short-course combination TB preventive therapy (TPT) regimens are highly effective with high completion rates and the...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Interview 1:
- Adult caregiver (18 years of age or older) of a child (\<15 years of age) who was exposed to TB in the last two years where at least one child was evaluated for and offered either TB preventive therapy or TB treatment.
- or
- Community health team members from one of the Ethiopian or South African clinics in which the CHIP-TB trial will be conducted.
- or
- TB nurse from one of the 16 Ethiopian or South African clinics in which the study will be conducted
- or
- Pediatrician or medical officer working in pediatrics at the relevant Ethiopian or South African District Hospital who sees outpatient pediatric consultations including TB-exposed children
- or
- Program manager or policy maker in the relevant Ethiopian or South African district or provincial office who manages TB, PMTCT, and/or other pediatric programming
- Exclusion Criteria for Interview 1:
- Any adult caregivers, community health team members, TB nurses, medical officers or pediatricians, program managers or policy makers who are unable or unwilling to provide informed consent for both the interview and audio-recording
- Inclusion Criteria for Interview 2:
- Any community health team members, TB nurses, medical officers or pediatricians, program managers or policy makers who participated in the program for at least 3 months
- Any adult caregiver whose child participated in the community-based TB prevention program
- Exclusion Criteria for Interview 2:
- Any adult caregivers, community health team members, TB nurses, medical officers or pediatricians, program managers or policy makers who are unable or unwilling to provide informed consent for both the interview and audio-recording
Exclusion
Key Trial Info
Start Date :
June 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT04494516
Start Date
June 4 2021
End Date
June 30 2023
Last Update
July 12 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
KNCV Tuberculosis Foundation
Addis Ababa, Ethiopia
2
The Aurum Institute
Johannesburg, South Africa